MERCK KGAA NAM.SP.ADR (MRKC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.045x

Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.29 Billion ≈ $1.51 Billion USD) by net assets (€28.66 Billion ≈ $33.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MERCK KGAA NAM.SP.ADR (MRKC) total market value for the company's overall valuation and market capitalisation.

MERCK KGAA NAM.SP.ADR - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how MERCK KGAA NAM.SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MERCK KGAA NAM.SP.ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their cash flow conversion efficiency. Explore MERCK KGAA NAM.SP.ADR cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hyundai Electric & Energy Systems Co Ltd
KO:267260
0.062x
IHH Healthcare Bhd
KLSE:5225
0.029x
Hanwha Ocean Co., Ltd
KO:042660
-0.062x
Hengli Petrochemical Co Ltd
SHG:600346
0.009x
Fortive Corp
NYSE:FTV
0.047x
Alliant Energy Corp
NASDAQ:LNT
0.050x
RENAU.UNSP.ARD 1/5 EO-20
F:56S0
0.035x
SDIC Power Holdings Co Ltd
SHG:600886
0.087x

Annual Cash Flow Conversion Efficiency for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual cash flow conversion efficiency of MERCK KGAA NAM.SP.ADR from 2020 to 2025. View current stock price of MERCK KGAA NAM.SP.ADR for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €28.66 Billion
≈ $33.51 Billion
€3.93 Billion
≈ $4.60 Billion
0.137x -10.29%
2024-12-31 €29.99 Billion
≈ $35.06 Billion
€4.59 Billion
≈ $5.36 Billion
0.153x +8.13%
2023-12-31 €26.75 Billion
≈ $31.28 Billion
€3.78 Billion
≈ $4.42 Billion
0.141x -13.64%
2022-12-31 €26.00 Billion
≈ $30.40 Billion
€4.26 Billion
≈ $4.98 Billion
0.164x -24.02%
2021-12-31 €21.42 Billion
≈ $25.04 Billion
€4.62 Billion
≈ $5.40 Billion
0.216x +5.49%
2020-12-31 €17.02 Billion
≈ $19.89 Billion
€3.48 Billion
≈ $4.06 Billion
0.204x --

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1479 Global
#329 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more